The FDA announced it had approved Elidel ( pimecrolimus ) cream for treating mild to moderate forms of the skin condition called atopic dermatitis, or eczema. The skin condition is common, causing red, swollen, and itchy rashes that often seep and ooze. The drug maker, Novartis, notes more than 40 million people in the U.S. develop flare-ups of eczema.
It is a prescription cream for the skin condition called atopic dermatitis or eczema. It is intended for people who can't use other standard skin medications.
Typically, doctors use steroids to treat eczema, which fight against swelling and inflammation but often bring side effects. Novartis reports there were side effects in the drug trials, but they were mild when compared to those who received a placebo cream.